|
Research & Development
|
91.75M | 142.72M | 200.93M |
|
Selling, General & Administrative
|
31.12M | 45.48M | 62.54M |
|
Other Operating Expenses
|
13.00M | 63.90M | |
|
Operating Expenses
|
135.87M | 252.10M | 263.46M |
|
Operating Income
|
-135.87M | -252.10M | -263.46M |
|
EBIT
|
-135.87M | -252.10M | -263.46M |
|
Interest & Investment Income
|
4.56M | 16.61M | 19.93M |
|
Other Non Operating Income
|
0.41M | -0.17M | -0.08M |
|
Non Operating Income
|
4.97M | 16.44M | 19.86M |
|
EBT
|
-130.90M | -235.66M | -243.61M |
|
Tax Provisions
|
| 0.27M | 0.18M |
|
Profit After Tax
|
-130.90M | -235.93M | -243.79M |
|
Income from Continuing Operations
|
-130.90M | -235.93M | -243.79M |
|
Consolidated Net Income
|
-130.90M | -235.93M | -243.79M |
|
Income towards Parent Company
|
-130.90M | -235.93M | -243.79M |
|
Net Income towards Common Stockholders
|
-130.90M | -235.93M | -243.79M |
|
EPS (Basic)
|
-0.00M | -0.00M | -0.00M |
|
EPS (Weighted Average and Diluted)
|
-0.00M | -0.00M | -0.00M |
|
Shares Outstanding (Weighted Average)
|
137.24M | 152.70M | 161.56M |
|
EBITDA
|
-131.68M | -235.23M | -243.65M |